BRIEF published on 07/25/2025 at 08:50, 1 year 3 months ago Adocia and Tonghua Dongbao Report Phase 3 Success for Ultra-Rapid Insulin Diabetes Treatment Clinical Trial Phase 3 Results ADOCIA BioChaperone® Lispro
PRESS RELEASE published on 07/25/2025 at 08:45, 1 year 3 months ago Informations privilégiées / Autres communiqués ADOCIA et Tonghua Dongbao annoncent des résultats positifs de l'essai clinique de Phase 3 sur l'insuline ultra-rapide BioChaperone® Lispro pour le diabète de Type 2 en Chine Essai Clinique Diabète De Type 2 ADOCIA Tonghua Dongbao Insuline Ultra-rapide
PRESS RELEASE published on 07/25/2025 at 08:45, 1 year 3 months ago Inside Information / Other news releases Adocia and Tonghua Dongbao announce positive Phase 3 results of Ultra-Rapid Insulin BioChaperone® Lispro (THDB0206 injection) in Type 2 Diabetes. Significant HbA1c reduction and improved post-meal blood glucose levels compared to Humalog® Type 2 Diabetes Phase 3 Results ADOCIA Tonghua Dongbao Ultra-Rapid Insulin
BRIEF published on 04/04/2025 at 11:21, 1 year 6 months ago Vester Finance reduces its stake in ADOCIA Voting Rights Actions Threshold Crossing ADOCIA Vester Finance
BRIEF published on 04/04/2025 at 11:21, 1 year 6 months ago Vester Finance réduit sa participation dans ADOCIA Droits De Vote Franchissement De Seuil Actions ADOCIA Vester Finance
PRESS RELEASE published on 04/04/2025 at 11:16, 1 year 6 months ago Franchissement de seuil Déclaration de franchissement de seuil par Vester Finance pour 9,82% du capital de ADOCIA Franchissement De Seuil Marché ADOCIA Vester Finance 10%
BRIEF published on 02/28/2025 at 19:33, 1 year 7 months ago Adocia finalise un placement privé de 9,7 millions d'euros Capital Social Placement Privé Biopharmaceutique Traitement Du Diabète ADOCIA
BRIEF published on 02/28/2025 at 19:33, 1 year 7 months ago Adocia Completes €9.7 Million Private Placement Private Placement Share Capital Biopharmaceutical Diabetes Treatment ADOCIA
PRESS RELEASE published on 02/28/2025 at 19:28, 1 year 7 months ago Inside Information / Other news releases Adocia successfully settles and delivers €9.7 million private placement, issuing 2,125,000 new ordinary shares with warrants. Admittance to trading on Euronext Paris confirmed Private Placement Euronext Paris Diabetes Biopharmaceutical ADOCIA
PRESS RELEASE published on 02/28/2025 at 19:28, 1 year 7 months ago Informations privilégiées / Autres communiqués Adocia annonce le règlement-livraison de son placement privé de 9,7 millions d'euros, avec émission d'actions nouvelles et bons de souscription d'actions Placement Privé Biopharmaceutique Actions Nouvelles Bons De Souscription ADOCIA
Published on 10/28/2026 at 08:00, 1 hour 12 minutes ago Algo Grande Copper Makes New Skarn Discovery at Adelita; Step-Out Hole AG-CG-PH2-003 Returns a Combined 139.81 Metres of 1.3% CuEq from Cerro Grande and the New Margarita Skarn
Published on 10/28/2026 at 02:55, 6 hours 17 minutes ago Challenger Underground MRE Doubles to 230koz @ 3.65 g/t Au
Published on 10/28/2026 at 02:50, 6 hours 22 minutes ago Letter to Shareholders Regarding Annual General Meeting
Published on 10/27/2026 at 23:40, 9 hours 32 minutes ago Second Closing of US$3.4 Million Private Placement
Published on 10/27/2026 at 23:25, 9 hours 47 minutes ago Gamma Resources Announces Leadership Transition: C. Connor Messler to Become Chief Executive Officer and Gabriel Alonso-Mendoza to Become Chairman; Grants Incentive Stock Options
Published on 10/28/2026 at 09:05, 7 minutes ago Rivermate recognized as a key provider of EoR solutions in Everest Group's Employer of Record (EoR) Solutions PEAK Matrix® Assessment 2026
Published on 10/28/2026 at 09:00, 12 minutes ago Municipality Finance issues a GBP 30 million tap under its MTN programme
Published on 10/28/2026 at 09:00, 12 minutes ago PFISTERER Kontaktsysteme GmbH improves its sustainability rating and ranks among the top 3 percent of its industry
Published on 10/28/2026 at 08:00, 1 hour 12 minutes ago Edenred successfully raises €800 million in a dual-tranche bond offering
Published on 10/28/2026 at 08:00, 1 hour 12 minutes ago Edenred lève avec succès 800 millions d’euros dans le cadre d’une émission obligataire à deux tranches
Published on 10/27/2026 at 18:00, 15 hours 12 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 15 hours 12 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
